Metabolism-Clinical and Experimental

Article	Citations
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	815
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	635
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	234
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	222
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation	208
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	179
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	168
The role of active vitamin D in preventing sarcopenia—Authors' reply	139
Editorial Board	139
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multic	137
Editorial Board	130
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST	125
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis	123
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	119
Sepsis-induced lipid droplet accumulation enhances antibacterial innate immunity through mechanisms dependent on DGAT-1 and interferon-beta	118
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	115
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	115
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	102
Angiopoietin-like protein 8 mediates inflammation and fibrosis of tubular cells in diabetic kidney disease progression by interacting with Akt2	91
Brown adipose tissue-derived metabolites and their role in regulating metabolism	90
PCSK9 in metabolism and diseases	89
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy	89
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	86
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	79
Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men	78

Protein oxidation in non-exercising healthy adults under varying dietary conditions: Physiological determinants, effects on fuel partitioning, and implications for body weight regulation	77
Editorial Board	77
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models	76
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus	70
Association between hypertension and severity of NAFLD among adults with obesity	70
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	68
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease	67
Exercise training increases skeletal muscle sphingomyelinases and affects mitochondrial quality control in men with type 2 diabetes	67
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	66
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review	66
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	65
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	64
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	63
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	63
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health	62
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics	62
Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor	60
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R	59
Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegeneration	59
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications	58
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis	58
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity	58
Role of mitochondria in pathogenesis and therapy of renal fibrosis	58
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	58
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis	56
Role of Coronary Artery Calcium in the Association Between Hormone Replacement Therapy Status and Incident Death and Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis	54
Editorial Board	54
Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia	52
Biological effect of nicotiflorin against acute myocardial Infarction: Therapeutic role in the medicine through scientific data analysis	51
Real-world outcomes in people with type 2 diabetes (PWD2) and renal impairment receiving insulin glargine 300 U/mL (Gla-300) and insulin degludec 100U/mL or 200U/mL (IDeg): the DELIVER-R study	50
Editorial Board	50
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences	49
Editorial Board	48
Editorial Board	48
Best practice recommendations for the diagnosis and management of hypoparathyroidism	47
NPRC promotes hepatic steatosis via USP30-mediated deubiquitination of C/EBPβ	47
Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at	46
The LS-IM score and its relation to direct measurements of insulin resistance	46
Corrigendum to “Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise” [Metabolism, Volume 168, July 2025, 156	46
Nutritional Management of Patients with Obesity in Critical Care	46
Clinical and Biochemical Characteristics of Children and Adolescents with Type 1 Diabetes in Mexico	46
Insulin Resistance as Monitored by Dynamic Light Scattering of Whole Human Serum: An Ancillary Study of PREMIER	46
NIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagy	46
Association of eating-out rate with metabolic syndrome in Korean adults: from the Korean National Health and Nutrition Examination Survey 2016	46
Biological importance of prunin in the medicine for the treatment of diabetes related complication: Therapeutic benefit through data analysis	46
Identifying proteins and pathways associated with multimorbidity in 53,026 adults	46
Endothelial sodium channel activation mediates DOCA-salt-induced endothelial cell and arterial stiffening	45
Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis	45
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies	44
Suppression of hepatosteatosis by isarubrolone C through AMPK-dependent regulation of lipophagy and lipid metabolism	44

A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts	44
Relationship between circulating adipokines and cholesterol efflux in subjects with severe carotid atherosclerosis	43
Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment	42
Editorial Board	41
Inverse Relationship Between Creatinine-to-Body Weight (Cre/BW) Ratio and Incident Diabetes in a Multiethnic Cohort	40
Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy	40
New PET Measures of Functional Brain Fractal Dimensions Show Significant Differences for Cortical Grey and White Matter and also in Near Normal vs. Insulin Resistant Patients	40
Association Between Processed and Ultra-processed Food Intake and Cardiovascular Disease and its Risk Factors in Patients with Type 2 Diabetes	40
Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19	38
Disrupted metabolic flux balance between pyruvate dehydrogenase and pyruvate carboxylase in human fatty liver	37
Omentin-1 Levels and Endothelial Dysfunction in Diabetic Kidney Disease	37
Uric Acid and Treatment With Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF): the EMPEROR-Preserved Trial	37
Corrigendum to “The RNA binding protein HuR influences skeletal muscle metabolic flexibility in rodents and humans” [Metab. 97 (2019) 40–49]	36
Anti-inflammatory activity of corylin in the medicine: Biological importance through scientific data analysis	35
Fat mass paradox and carotid intima-media thickness progression: A longitudinal study from childhood through young adulthood	34
Multiple Autoimmune Syndromes in Type 1 Diabetes	34
T2DM Subgroups and Response to Glucose-lowering Therapy: Results from EDICT and Qatar Study	33
Commentary on the endocrine society clinical practice guideline on the “treatment of hypercalcemia of malignancy in adults”	33
The Association Between Adiponectin and Myocardial Infarction in Patients with Nonalcoholic Fatty Liver Disease	33
Prevalence of Hypercortisolism in Patients with Difficult-to-control Type 2 Diabetes: Final Results from CATALYST Part 1	33
SACUBITRIL/VALSARTAN TREATMENT MAY BE ASSOCIATED WITH IMPROVED FRONTAL PLANE QRS-T ANGLE AND CARDIAC REPOLARIZATION PARAMETERS.	33
O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36	33
Response to letter to the editor regarding: “Plasma metabolite profiles of meat intake and their association with cardiovascular disease risk: A population-based study in Swedish cohorts” by Arage et	33
Females have a different metabolic response to critical illness, measured by comprehensive amino acid flux analysis	32
Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy	32
Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism	32
Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes	32
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases	31
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts	31
Olfactomedin 2 deficiency protects against diet-induced obesity	31
Recent advances and therapeutic applications of PPARγ-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation	31
High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity	31
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection	31
Interplay of lipid metabolism and inflammation in podocyte injury	31
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis	30
Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications	30
C3aR1 on beta cells preserves beta cell function and glucose homeostasis in diabetic mice by decreasing metabolic stress and dedifferentiation	29
The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions	29
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation	29
Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways	29
The Role of Insulin Resistance in the Severity of PCOS Among a Population in Albania	28
Biological effect of ginkgetin on kidney injury: Health benefit in the medicine through scientific data analysis	28
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic Patients	28
New onset Diabetes Mellitus in a COVID-19 patient: A Case report	28
Patients With Diabetic Ketoacidosis Affected By Protein Calorie Malnutrition Have In-Patient High Mortality And Increased Resource Utilization, Nation Wide Study	28
Blood C-Peptide Values are Impacted by the Collection, Storage and Evaluation Methods	27
Evaluation of the effect of β-Caryophyllene on oxidative stress in BALB / c mice with streptozotocin-induced diabetes	27
METTL1-mediated m7G methylation of FoxO1 regulates lipid metabolism in metabolic dysfunction-associated fatty liver disease	27
Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure	27
Editorial Board	27
Sodium-dependent Glucose Transporter 2 Inhibitor Alleviates Renal Lipid Deposition and Improves Renal Oxygenation Levels in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Randomized Controlled T	27
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming	27
Emerging roles of TRIM in metabolic regulation	27
The chemokine CCL20 promotes hepatocyte cholesterol deposition during metabolic dysfunction-associated steatohepatitis by regulating OLR1 expression	27
Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor	27
Arrestin domain containing 3 promotes alcohol-induced liver steatosis by reducing stearoyl-CoA desaturase-1 ubiquitinated degradation	26
Dyslipidemia Correction by Combination of Statin and Choline Fenofibrate in Diabetic Patients with Multifocal Atherosclerosis	26
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response	26
Effects of Semaglutide on Metabolic Syndrome Parameters in Non-Diabetics: A Meta-analysis of Randomized Controlled Trials	26
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation - author's reply	26
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank	26
NRH, a potent NAD+ enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway	26
Copper impairs the intestinal barrier integrity in Wilson disease	25
Corrigendum to “Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19” [Metabolism volume 160 (2024) 155980]	25
Propionyl-L-Carnitine in Patients with Type 2 Diabetes and Peripheral Artery Disease	25
VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis	25
Association of PNPLA3 and TM6SF2 Polymorphisms with NAFLD in Greek People with Type 2 Diabetes Mellitus	25
Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study	25
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled	25
Myocardial Ischemia in Type 2 Diabetic Patients	25
EFFECT OF ADMINISTRATION OF AVOCADO JUICE (PERSEA AMERICANA MILL) ON RAT-INDUCED MALONDIALDEHID (RATTUS NORVEGICUS) LEVELS	24
Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models	24
Role of SORT1 gene in patients with Coronary Artery Disease.	24
Prevalence and Clinical Characteristics of Patients with Transthyretin Amyloidosis in the United States and Japan: Results from the OverTTuRe Study	24
Trends in Hyperinsulinemia Among U.S. Adults without Diabetes: A Joinpoint Analysis	24
Sodium-glucose cotransporter-2 inhibitors: A treatment option for recurrent vasovagal syndrome?	24
Acknowledgement to reviewers	23
Editorial Board	23
Correlation of Insulin Resistance, Type 2 Diabetes Mellitus, Obesity, and Colorectal Cancer Occurrence	23
Identifying genetic determinants of sarcopenia-related traits: a Mendelian randomization study of druggable genes	22

Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice	22
The role of histone deacetylases in cardiac energy metabolism in heart diseases	22
Postpartum defects in inflammatory response after gestational diabetes precede progression to type 2 diabetes: a nested case-control study within the SWIFT study	22
GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies	22
Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets	22
Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated repression of kisspeptin actions in GnRH neurons	22
Metabolites-mediated posttranslational modifications in cardiac metabolic remodeling: Implications for disease pathology and therapeutic potential	22
Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption	21
The zebrafish model system for dyslipidemia and atherosclerosis research: Focus on environmental/exposome factors and genetic mechanisms	21
Reply to: “Precision nutrition in aging: Enhancing frailty prevention through personalized dietary interventions”	21
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond	21
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD	21
Efficacy and Safety of Tirzepatide in Type 2 Diabetes: The SURPASS Clinical Trial Program	21
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study	21
Thymoquinone: A Promising Anti-diabetic Molecule!	21
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study	21
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease	21
Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease	21
Primary cilia regulate adaptive responses to fasting	21
Therapeutic importance of eriodictyol in the medicine for the treatment of diabetes and associated complication through its insulin secretagogue properties	20
Corrigendum to ‘Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nep	20
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease	20
Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation	20
Effects Of Late Onset Estradiol Treatment On Insulin Resistance And Lipid Metabolism In High-Fat-Fed Ovariectomized Female Mice	20
Editorial Board	20
Insulin resistance and miR-143/miR-145 relative expression profile is associated with dysregulation in the pathological adiposity setting in aging	20
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control stu	20
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter	20
Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages	20
Disruptive factors of treatment adherence of diabetic patients in downtown Sfax from Tunisia – a community pharmacy-based survey	20
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland	20
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice	20
Lysine potentiates insulin secretion via AASS-dependent catabolism and regulation of GABA content and signaling	20
New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies	19
Value of breastfeeding in Pregnant with gestational diabetes mellitus	19
Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury	19
LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease	19
Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism	19
Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice	19
Recent advances in closed-loop insulin delivery	19
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus	19
Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis	19
Prognostic Fasting Insulin Cut Points for Hidden Diabetes Risk among Apparently Healthy Young Adults: CARDIA 30-year Follow Up	19
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and Cardiovascular Disease: Results from CATALYST	19
Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes	19
Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus	19
A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial	19
FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD+ axis	19
Anti-atherosclerosis activity of meranzin hydrate in the medicine: Therapeutic benefit through scientific data analysis	18
Unraveling the roles of mitochondrial sirtuins in aging-related diseases: From mechanistic insights to therapeutic strategies	18
EVALUATION OF 1-HOUR POST LOAD GLUCOSE LEVELS, THE METABOLIC SYNDROME AND FINDRISC SCORES IN THE PREDICTION OF T2DM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE	18
Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease	18
TAS2R38 taste receptor gene and metabolically unhealthy obesity	18
A Rare Cause of Severe Insulin Resistance: A Case Report	18
Intravital imaging reveals glucose-dependent cilia movement in pancreatic islets in vivo	18
Associations of single nucleotide variants of the FTO gene with metabolic disorders in children with obesity	18
The Association Between Gestational Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Literature Review	17
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression	17
Metabolic complications of highly active antiretroviral therapy in adult HIV-infected patients with heart failure: A 7-year prospective cohort study	17
The bone-heart axis: A crucial dialogue in cardiovascular disease	17
FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase	17
Transplantation of bone marrow cells from miR150 knockout mice improves senescence-associated humoral immune dysfunction and arterial stiffness	17
Alteration of IGF-1 bioavailability due to PAPPA2 deficiency leads to sex-specific metabolic disturbances	17
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy	17
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States	17
Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner	17
Omega-3 Fatty Acids intervention and DASH Diet Ameliorates Metabolic profiling in Patients with Diabetes Mellitus Type 2	17
Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential	17
DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice	16
GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway	16
Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma	16
Liraglutide in Treatment of Diabetes Mellitus Type 2: Systematic Review and Bibliometric Analysis Over The Last Two Decades	16
Incretin-based therapy and atrial fibrillation risk in overweight or obesity	16
Insulin Resistance Probability Score and Cardiovascular Events in the Elderly	16
Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise	16
Editorial Board	16
Circulating Total and Intact GDF-15 Levels are Not Altered in Response to Weight Loss Induced by Liraglutide and/or Lorcaserin Treatment in Humans with Obesity and/or Diabetes	16
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need	16
Time-restricted eating and its impact on weight loss, adipose tissue distribution, lean mass and blood pressure in women with cardiometabolic risk factors	16
Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity	16
REEP6 knockout leads to defective β-adrenergic signaling in adipocytes and promotes obesity-related metabolic dysfunction.	15
Aldosterone Dysregulation and Type 2 Diabetes Mellitus Are Associated with Prevalent Risk of Hypertension: BREAKTHROUGH Risk Study	15
Leptin receptor neurons in the dorsomedial hypothalamus require distinct neuronal subsets for thermogenesis and weight loss	15
Flot2 protects against podocyte injury by maintaining the stability of synaptopodin in diabetic nephropathy	15
The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis	15
Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity	15
Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation	15
Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice	15
Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019	15
Metabolic obesity phenotypes: a friend or foe of digestive polyps?—An observational study based on National Inpatient Database	15
Long Term Effectiveness of the Latest Categories of Antidiabetic Medication for Type 2 Diabetes. Outcomes of the Outpatient Diabetic Clinic of a Tertiary Hospital of Athens	14
Editorial Board	14
Corrigendum to “Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1” [Metabolism, Volume 163 (2025), Article Number 156087]	14
A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study	14
Adiponectin Gene Variants and their Association with Homa-Index, Adiponectin and Leptin Levels in Adult Metabolic Syndrome Women	14